PJSC Biokhimik will completely reconstruct the innovation facility at its production site in Saransk, that will host the R&D lab and workshops for chemical and microbiological synthesis of active pharmaceutical substances. Pharmcontract Group, a chemicals and pharmaceuticals holding company, was selected as the general contractor.
The facility will be equipped with high-tech machinery manufactured in Switzerland, Germany and Italy.
In general, the modernization program includes the reconstruction of two existing facilities, as well as the construction of a new large facility to manufacture the medicines for parenteral administration. The project is expected to last 5 years and includes several stages to organize and support the manufacturing of Russian pharmaceutical substances and medicinal products in accordance with GMP standards.
This large-scale project of Biokhimik investment program is not just an important step towards ensuring the import substitution and facilitating the availability of high-quality Russian-made medicinal products. It is a key factor for pharmaceutical security of Russia, as provided by the programs for the development of Russian pharmaceutical industry.